Cargando…

Risks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic Review

Objectives. Assess the impact of associating thrombolytics, anticoagulants, antiplatelets, and primary angioplasty (PA) on death, reinfarction (AMI), and major bleeding (MB) in STEMI therapy. Methods. Medline search was performed to identify randomized trials comparing these classes in STEMI treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nascimento, Bruno Ramos, de Sousa, Marcos Roberto, Demarqui, Fábio Nogueira, Ribeiro, Antonio Luiz Pinho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933035/ https://www.ncbi.nlm.nih.gov/pubmed/24653840 http://dx.doi.org/10.1155/2014/416253

Ejemplares similares

COVID-19 and thrombotic complications—the role of anticoagulants, antiplatelets and thrombolytics
por: Khandelwal, Gaurav, et al.
Publicado: (2021)

Clinical Profile and Mortality of ST-Segment Elevation Myocardial Infarction Patients Receiving Thrombolytic Therapy in the Middle East
por: Panduranga, Prashanth, et al.
Publicado: (2012)

Factors Associated with Delay in Thrombolytic Therapy in Patients with ST-Elevation Myocardial Infarction
por: Alishahi Tabriz, Amir, et al.
Publicado: (2012)

Reviewing time intervals from onset of the symptoms to thrombolytic therapy in patients with ST segment elevation myocardial infarction (STEMI)
por: Moeini, Mahin, et al.
Publicado: (2010)

Early ST-segment elevation acute myocardial infarction after thrombolytic therapy for acute ischemic stroke: A case report
por: Manea, Maria Mirabela, et al.
Publicado: (2018)

A novel model for evaluating thrombolytic therapy in dogs with ST-elevation myocardial infarction
por: Zhang, Hong, et al.
Publicado: (2016)

Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in ST‐segment elevation myocardial infarction
por: Welsh, Robert C., et al.
Publicado: (2021)

Patient delay and benefit of timely reperfusion in ST-segment elevation myocardial infarction
por: Scholz, Karl Heinrich, et al.
Publicado: (2021)

Preintensive care: Thrombolytic (streptokinase or tenecteplase) in ST elevated acute myocardial infarction at peripheral hospital
por: Bawaskar, Himmatrao S., et al.
Publicado: (2019)

Post thrombolytic resolution of ST elevation in STEMI patients
por: Saleem, Sameer, et al.
Publicado: (2016)

Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction
por: Fernández-Bergés, Daniel, et al.
Publicado: (2020)

Characteristics and mechanism of reciprocal ST-segment depression in acute ST segment elevation myocardial infarction: Reciprocal ST-segment depression and ST segment elevation myocardial infarction
por: Gao, Qijun, et al.
Publicado: (2022)

Intracoronary arterial retrograde thrombolysis with percutaneous coronary intervention: a novel use of thrombolytic to treat acute ST-segment elevation myocardial infarction
por: Tian, Jin-Wen, et al.
Publicado: (2019)

Safety of Antiplatelet Pretreatment in Non-ST-segment Elevation Acute Coronary Syndrome
por: Torres-Ruiz, G, et al.
Publicado: (2023)

Ischemic stroke complicating thrombolytic therapy with tenecteplase for ST elevation myocardial infarction: two case reports
por: Arous, Salim, et al.
Publicado: (2017)

Anticoagulant and thrombolytic therapy in surgery /
por: Malinovskiĭ, Nikolaĭ N.
Publicado: (1979)

Left ventricular function, strain, and infarct characteristics in patients with transient ST-segment elevation myocardial infarction compared to ST-segment and non-ST-segment elevation myocardial infarctions
por: Demirkiran, Ahmet, et al.
Publicado: (2021)

Invasive and antiplatelet treatment of patients with non‐ST‐segment elevation myocardial infarction: Understanding and addressing the global risk‐treatment paradox
por: Ahrens, Ingo, et al.
Publicado: (2019)

An embolic ST-segment elevation myocardial infarction
por: Feng, Lv, et al.
Publicado: (2021)

Acute ST-segment elevation myocardial infarction: to be or not to be?
por: Barbur, Maria Carolina Manzur, et al.
Publicado: (2022)

The Severity of Coronary Arterial Stenosis in Patients With Acute ST-Elevated Myocardial Infarction: A Thrombolytic Therapy Study
por: Kilic, Salih, et al.
Publicado: (2018)

Prolonged dual antiplatelet therapy in patients with non‐ST‐segment elevation myocardial infarction: 2‐year findings from EPICOR Asia
por: Zou, Yanan, et al.
Publicado: (2020)

Effectiveness of dual antiplatelet de-escalation therapy on the prognosis of patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention
por: Zhao, Zhigang, et al.
Publicado: (2023)

aVR ST‐segment changes and prognosis of ST‐segment elevation myocardial infarction
por: Sedighi, Sogol, et al.
Publicado: (2021)

Factors associated with longer delays in reperfusion in ST-segment elevation myocardial infarction
por: Abreu, Daisy, et al.
Publicado: (2014)

False Positive ST-Segment Elevation Myocardial Infarction
por: Jeong, Hae Chang, et al.
Publicado: (2013)

Etiologies and Predictors of ST-Segment Elevation Myocardial Infarction
por: Bae, Myung Hwan, et al.
Publicado: (2013)

Anemia and Inflammation in ST-Segment Elevation Myocardial Infarction
por: Zhang, Enyuan, et al.
Publicado: (2015)

Impact of ST‐Segment–Elevation Myocardial Infarction Regionalization Programs on the Treatment and Outcomes of Patients Diagnosed With Non–ST‐Segment–Elevation Myocardial Infarction
por: Montoy, Juan Carlos C., et al.
Publicado: (2021)

Management of ST-elevation myocardial infarction in the setting of anterior epistaxis: focused on antiplatelet and antithrombotic therapies
por: Handoyo, Victoria, et al.
Publicado: (2019)

Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study
por: Adamski, Piotr, et al.
Publicado: (2017)

A Pleasant Surprise in the Face of ST-Segment Elevation
por: Sousa-Nunes, Fábio, et al.
Publicado: (2021)

Metabolic Disturbances Identified in Plasma Samples from ST-Segment Elevation Myocardial Infarction Patients
por: Goulart, Vânia Aparecida Mendes, et al.
Publicado: (2019)

Gender differences in mortality in patients with ST-segment elevation myocardial infarction
por: Raymundo-Martínez, Grecia I.M., et al.
Publicado: (2021)

Comparison of effects of thrombolytic therapy and primary percutaneous coronary intervention in elderly patients with acute ST-segment elevation myocardial infarction on in-hospital, six-month, and one-year mortality
por: Kocayigit, Ibrahim, et al.
Publicado: (2019)

Thrombolytic Therapy for ST-Elevation Myocardial Infarction Presenting to non-Percutaneous Coronary Intervention Centers During the COVID-19 Crisis
por: Walters, Daniel, et al.
Publicado: (2021)

Outcomes and Prognostic Impact of Prophylactic Oral Anticoagulation in Anterior ST‐Segment Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction
por: Shavadia, Jay S., et al.
Publicado: (2017)

Assessment of serum phenylalanine and tyrosine isomers in patients with ST‐segment elevation vs non‐ST‐segment elevation myocardial infarction
por: Al‐Sadoon, Ied, et al.
Publicado: (2020)

ST-segment elevation predicts the occurrence of malignant ventricular arrhythmia events in patients with acute ST-segment elevation myocardial infarction
por: Wang, Xianpei, et al.
Publicado: (2023)

New anticoagulant strategies in ST elevation myocardial infarction: Trials and clinical implications
por: McCann, Conor J, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_f9gjrindc83k6nuihdl29ie284